Real-time enrollment status for this pancreatic adenocarcinoma metastatic clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:05 PM UTC
| NCT Number | NCT07377045 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Adenocarcinoma Metastatic |
| Phase | Clinical Trial |
| Target Enrollment | 69 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Oncomatryx Biopharma S.L. |
| Last Updated on CT.gov | January 29, 2026 (Jan 29, 2026) |
As of July 13, 2026: Clinical trial NCT07377045 is currently recruiting participants. This clinical trial study for pancreatic adenocarcinoma metastatic is actively seeking new participants at 1 location across the United States. The study is sponsored by Oncomatryx Biopharma S.L.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07377045 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07377045 was last updated Jan 29, 2026 (January 29, 2026). HelloStudys verifies this status automatically.